No Data
No Data
Express News | GlucoTrack Shares Are Trading Higher After the Company Announced New Findings From a Recent Market Research Study Evaluating the Acceptance of Its New Continuous Blood Glucose Monitor Concept Among People With Insulin-requiring Diabetes
Express News | Reported Earlier: Glucotrack ADCES Poster Reveals Over 50% Of Surveyed Diabetes Patients Open To New Continuous Blood Glucose Monitor Concept, Offering Long-Term Monitoring Without Traditional CGM Challenges
GlucoTrack Shares Market Research Insights Publicly
Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates With Patients With Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
Glucotrack | 10-Q: Q2 2024 Earnings Report
GlucoTrack Showcases Innovations at Industry Conference
No Data